معرفی
Charlotta Nilsson serves as an Affiliated Researcher and Docent at Karolinska Institutet's Department of Laboratory Medicine, specifically within the Division of Clinical Microbiology at Labmed. Her research spans HIV vaccine development, diagnostic testing, and immunological responses in global health contexts, with extensive fieldwork in Sub-Saharan Africa. She maintains active collaborations across Tanzania, Mozambique, and Sweden.
- Docent, Karolinska Institutet (2015)
- Doctor of Philosophy, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet (2001)
Dr. Nilsson's research focuses on HIV vaccine immunogenicity, with particular expertise in prime-boost regimens (DNA/MVA), envelope-specific antibody responses, and diagnostic interference from vaccine-induced seroreactivity. Her work frequently addresses challenges in resource-limited settings, including rapid test validation, co-infection dynamics (HIV/HBV), and implementation barriers for vaccination programs. Recent expansions include SARS-CoV-2 immune response characterization following heterologous vaccination.
Analysis of her 15 most recent publications reveals dominant themes in HIV envelope immunology (particularly V1V2 responses), vaccine trial methodology in African populations, and diagnostic assay validation. The work consistently bridges basic virology with clinical implementation, emphasizing translational research that addresses real-world diagnostic and vaccination challenges in endemic regions.
Her laboratory-based research operates within Karolinska Institutet's Department of Laboratory Medicine infrastructure, leveraging advanced virology and immunology platforms. Collaborative networks include the Karolinska University Hospital's clinical microbiology division and international partnerships with research groups in Tanzania (Muhimbili University) and Mozambique (National Institute of Health).
